These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10766326)

  • 1. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.
    García Rodríguez LA; Ruigómez A; Wallander MA; Johansson S; Olbe L
    Scand J Gastroenterol; 2000 Mar; 35(3):306-11. PubMed ID: 10766326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study.
    Canavan C; Card T; West J
    PLoS One; 2014; 9(9):e106478. PubMed ID: 25238408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
    Fujiwara Y; Kubo M; Kohata Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Intern Med; 2011; 50(21):2443-7. PubMed ID: 22041340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome.
    Porter CK; Cash BD; Pimentel M; Akinseye A; Riddle MS
    BMC Gastroenterol; 2012 May; 12():55. PubMed ID: 22639930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Irritable Bowel Syndrome, Functional Dyspepsia and their Overlap in Bulgaria: a Population-Based Study.
    Nakov R; Dimitrova-Yurukova D; Snegarova V; Uzunova M; Lyutakov I; Ivanova M; Madzharova K; Valkov H; Hristova R; Ivanov K; Kosturkov I; Valcheva G; Nakov N; Nakov V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):329-338. PubMed ID: 32919417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
    Szilagyi A; Xue X
    Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based study.
    Hsiao CW; Huang WY; Ke TW; Muo CH; Chen WT; Sung FC; Kao CH
    Eur J Intern Med; 2014 Jan; 25(1):82-6. PubMed ID: 24268837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time.
    Agréus L; Svärdsudd K; Nyrén O; Tibblin G
    Gastroenterology; 1995 Sep; 109(3):671-80. PubMed ID: 7657095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.
    Hammer J; Eslick GD; Howell SC; Altiparmak E; Talley NJ
    Gut; 2004 May; 53(5):666-72. PubMed ID: 15082584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
    Ruigómez A; García Rodríguez LA; Panés J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.
    Kaji M; Fujiwara Y; Shiba M; Kohata Y; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1151-6. PubMed ID: 20594232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of overlap between functional dyspepsia and overactive bladder.
    Matsuzaki J; Suzuki H; Fukushima Y; Hirata K; Fukuhara S; Okada S; Hibi T
    Neurogastroenterol Motil; 2012 Sep; 24(9):821-7. PubMed ID: 22616664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.